Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/9/2021
Antibe Therapeutics and Nuance Pharma Announce Strategic Licensing Dea...
2/9/2021
NDA for Amarin's VASCEPA (icosapent ethyl) Accepted in China
2/9/2021
Chance Pharma In-Licenses Drug-Device Combo AER-901 from Aerami Ther...
2/9/2021
Drug Farm Closes $56M Financing to Advance Lead Hepatitis B Drug into ...
2/9/2021
NMPA Issues the Announcement on Post-Marketing Drug Changes and Dosser...
2/9/2021
CDE Issues the Technical Guidelines for Research of Generic Fulvestran...
2/9/2021
CDE Issues the Technical Guidelines for Clinical Trial of Human Immuno...
2/9/2021
CDE Issues the Technical Guidelines for Clinical Testing of Immune Cel...
2/9/2021
SCMP: Phase One Trade Deal Largely A "Failure", As Purchases Fall Well...
2/9/2021
NLR: China's Patent Office Releases Draft Measures for Patent Linkage ...
2/8/2021
Kantar: Chinese Physicians' Digital Behaviour During COVID-19 Outbreak
2/8/2021
Bayer Receives Approval for Nubeqa in China for the Treatment of Men ...
2/8/2021
Sinovac's COVID-19 Vaccine Granted Conditional Approval in China as WH...
2/8/2021
CDE Issues the Technical Guidelines for Clinical Pharmacokinetics of T...
2/8/2021
BMS Granted Priority Review for NDA of Luspatercept in China
2/8/2021
IQVIA Conducts Survey of Physician Behaviors at the Internet Clinic Pl...
2/5/2021
JBM Healthcare Debuts IPO on the Main Board of HKSE
2/5/2021
CMS Acquires Dermatology Specialty Firm Luqa
2/5/2021
NMPA Holds National Drug Registration and Post Marketing Regulation Co...
2/4/2021
Local Drugmakers Dominated China's 4th Round of National VBP Again, As...
2/4/2021
Roche Reports Solid Results in 2020 with Mixed China Performance Highl...
2/4/2021
Former UF Professor Indicted for Defrauding NIH and Concealed Conflic...
2/4/2021
CDE Issues the Technical Guidelines for Clinical Trial of Omalizumab B...
2/4/2021
Wyeth Wins Trademark Infringement and Unfair Competition Lawsuit in C...
2/4/2021
Xuanzhu Pharma Takes Over Combio to Expand Biologics Pipeline
2/4/2021
Boehringer Sues China's Qilu Pharma in the U.S. over Patent Infringeme...
2/4/2021
Changes To Biotech And Chemical Patent Examination - Recent Amendments...
2/3/2021
AJMC: China Pulls Out Stops for Biosimilar Development
2/3/2021
Illumina and Sequoia Capital China Announce Deal to Incubate Genomics...
2/3/2021
NMPA Publicizes the List of Reference Formulations for GQCE Studies (4...
Page:
215
/
790
Total number of articles:
23678
:
[First]
[<<]
[213]
[214]
[215]
[216]
[217]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit